Evidence map›Paper›PMID 40764348›Full record

ArticleScientific reports2025

NanoTag is an improved method to map interactions between DNA and proteins not requiring IgG.

Maria A Dimitriu, Rodrigo G Arzate-Mejía, Leonard C Steg, Pierre-Luc Germain, Isabelle M Mansuy

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria A DimitriuLaboratory of Neuroepigenetics, Department of Health Sciences and Technology, Brain Research Institute, Medical Faculty of the University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.
Rodrigo G Arzate-MejíaLaboratory of Neuroepigenetics, Department of Health Sciences and Technology, Brain Research Institute, Medical Faculty of the University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.
Leonard C StegLaboratory of Neuroepigenetics, Department of Health Sciences and Technology, Brain Research Institute, Medical Faculty of the University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.
Pierre-Luc GermainComputational Neurogenomics, Department of Health Sciences and Technology, Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.
Isabelle M MansuyLaboratory of Neuroepigenetics, Department of Health Sciences and Technology, Brain Research Institute, Medical Faculty of the University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland. imansuy@ethz.ch.

Funding

Eidgenössische Technische Hochschule Zürich 20-1 FEL-28Eidgenössische Technische Hochschule Zürich ETH-10 15-2European Union Horizon 2020 Research Innovation Program EarlyCause 848158National Centre of Competence in Research (NCCR) RNA&Disease 182880/Phase 2Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 31003A_175742/1
6 · The paper itself

Abstract

Genome-wide profiling of DNA-protein interactions in cells can provide important information about mechanisms of gene regulation. Most current methods for genome-wide profiling of DNA-bound proteins such as ChIP-seq and CUT&Tag use conventional IgG antibodies to bind the target protein(s). This limits their applicability to targets with available high affinity and specificity antibodies and prevents their use for other targets. Here we describe NanoTag, an IgG-free method derived from CUT&Tag to profile DNA-protein interactions. NanoTag is based on a fusion between an anti-GFP nanobody and Tn5 transposase that can map GFP-tagged proteins associated with chromatin in a fast, cost-effective and animal-free manner. We used NanoTag to indirectly profile the histone mark H3K4me3 genome-wide via its binding partner TATA box-binding protein-associated factor 3 (TAF3) and the transcription factors Nanog and CTCF in mouse embryonic stem cells (mESCs). NanoTag results show high inter-replicate reproducibility, high signal-to-noise ratio and strong correlation with CUT&Tag datasets, validating its accuracy and reliability. NanoTag provides a novel, flexible and cost-effective IgG-free method to generate high resolution DNA-binding profiles in cells and tissues.

Indexed as

DNADNA-Binding ProteinsAnimalsChromatinHistonesImmunoglobulin GMiceMouse Embryonic Stem CellsProtein BindingChromatinDNADNA-Binding ProteinsHistonesImmunoglobulin GChromatinChromatin profilingCUT&TagDNA–protein interactionsEpigenomicsNanobodyTn5 tagmentation

Identifiers

PMID40764348
PMCPMC12325602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.